Bicocca Open Archive

Logo unimib boa
ALBERTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.157
AS - Asia 15.478
EU - Europa 9.675
SA - Sud America 1.620
AF - Africa 196
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 15
Totale 46.188
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.713
VN - Vietnam 5.099
SG - Singapore 4.500
CN - Cina 2.714
IT - Italia 2.231
HK - Hong Kong 1.767
RU - Federazione Russa 1.620
DE - Germania 1.501
BR - Brasile 1.317
SE - Svezia 1.102
IE - Irlanda 883
GB - Regno Unito 528
UA - Ucraina 387
CA - Canada 298
IN - India 281
FI - Finlandia 256
KR - Corea 232
FR - Francia 210
TR - Turchia 155
AT - Austria 154
JP - Giappone 154
ID - Indonesia 149
LT - Lituania 132
AR - Argentina 127
NL - Olanda 120
DK - Danimarca 119
ES - Italia 109
MX - Messico 98
BD - Bangladesh 92
ZA - Sudafrica 82
PL - Polonia 69
BE - Belgio 60
IQ - Iraq 55
EC - Ecuador 53
AU - Australia 42
PK - Pakistan 42
CH - Svizzera 40
CO - Colombia 35
SA - Arabia Saudita 30
GR - Grecia 27
TW - Taiwan 26
UZ - Uzbekistan 26
VE - Venezuela 23
MA - Marocco 22
IL - Israele 21
PY - Paraguay 20
EG - Egitto 19
RO - Romania 18
IR - Iran 17
MY - Malesia 16
PE - Perù 16
PT - Portogallo 16
KZ - Kazakistan 14
TN - Tunisia 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
EU - Europa 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
JO - Giordania 11
KE - Kenya 11
CL - Cile 10
TH - Thailandia 10
AZ - Azerbaigian 9
CR - Costa Rica 9
HR - Croazia 9
LV - Lettonia 9
DZ - Algeria 8
ET - Etiopia 8
HU - Ungheria 8
AL - Albania 7
BH - Bahrain 7
GT - Guatemala 7
JM - Giamaica 7
NG - Nigeria 7
NO - Norvegia 7
PA - Panama 7
PH - Filippine 7
SC - Seychelles 7
AO - Angola 6
BO - Bolivia 6
NP - Nepal 6
SI - Slovenia 6
BN - Brunei Darussalam 5
HN - Honduras 5
DO - Repubblica Dominicana 4
LU - Lussemburgo 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
IS - Islanda 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
Totale 46.160
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.158
Dallas 2.676
Singapore 2.629
Hong Kong 1.755
Ho Chi Minh City 1.562
Ashburn 1.485
Hanoi 1.257
Fairfield 860
Dublin 857
Milan 836
Woodbridge 831
Wilmington 792
Frankfurt am Main 733
Chandler 718
Houston 569
Dearborn 505
New York 490
Santa Clara 483
Hefei 392
Seattle 378
Beijing 375
Jacksonville 367
Los Angeles 356
Princeton 330
Cambridge 293
Nanjing 211
Munich 192
Seoul 178
Shanghai 154
The Dalles 154
Haiphong 152
Moscow 150
Chicago 147
Da Nang 145
São Paulo 144
Guangzhou 141
Boardman 139
Buffalo 137
Ha Long 131
Helsinki 120
Vienna 119
Vilnius 115
Jakarta 112
Quận Bình Thạnh 107
Biên Hòa 96
Hải Dương 95
Lawrence 94
Tokyo 79
Ninh Bình 78
Rome 78
Thái Nguyên 78
Altamura 77
London 74
Vũng Tàu 74
Can Tho 72
Dong Ket 69
Bắc Ninh 67
Toronto 67
Council Bluffs 61
Denver 61
Nuremberg 58
Quận Một 58
Shenyang 58
Montreal 57
Lachine 55
Nanchang 55
San Diego 53
Stockholm 53
Warsaw 53
Andover 52
Phoenix 52
Poplar 52
Tianjin 50
Atlanta 49
Bắc Giang 49
Changsha 48
Hangzhou 48
Rio de Janeiro 47
Brooklyn 45
Carate Brianza 45
Kent 45
Chennai 44
San Jose 42
Orem 41
Brussels 40
Hebei 40
Jinan 39
Vinh 39
Mexico City 38
Pune 38
Turku 38
Phủ Lý 37
Amsterdam 36
Boston 36
Quận Phú Nhuận 36
Ottawa 35
Quận Sáu 35
Turin 35
Johannesburg 33
Mountain View 32
Totale 30.451
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin-induced Alteration of Sodium-Calcium Exchanger as a Pivotal Element Leading to Peripheral Neurotoxicity and Necroptosis 699
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 580
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 551
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 533
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 508
Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity - Neurophysiology: the Link between Bed and Bench "side" 458
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity 448
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 447
A PILOT STUDY ON HEALTH-ECONOMICS BURDEN DUE TO CHEMOTHERAPY-INDUCED NEUROTOXICITY 446
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 422
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 401
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 400
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 389
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 384
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 380
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 372
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 366
Neuropatie periferiche da chemioterapia 357
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 343
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 334
Guillain-Barré syndrome related to COVID-19 infection 334
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 330
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 329
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 320
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 315
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 308
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 306
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 296
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper 293
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 293
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 288
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 279
3D Digital tools in neuro-anatomy teaching: from peer-to-peer tutoring to clinically oriented approaches 276
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 276
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 270
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 269
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 267
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 261
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 260
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 260
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 257
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 257
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 255
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 255
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 252
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 252
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 250
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 250
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 249
Severe, reversible nelarabine-induced neuropathy and myelopathy 249
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 248
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 245
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study 244
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 241
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 240
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 240
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 238
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 238
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data 238
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 236
Histone deacetylases inhibitors: a new frontier for neuroprotection? 232
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 232
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 231
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 230
Guillain–Barré Syndrome Associated with COVID-19 230
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 230
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 228
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 222
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 221
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 220
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 219
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 219
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
Neurophysiological examination of dorsal sural nerve 217
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study 213
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 213
Chemotherapy-induced neuropathy 212
In vivo study of Carfilzomib-Induced Neuropathy 212
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
When progressive dysphagia could be related to an “old friend” – a case report 208
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 206
Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research 206
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 204
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study 204
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 203
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 202
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 202
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 201
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy. 200
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial 200
Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy 198
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 196
NERVE EXCITABILITY TESTING IN ANIMAL MODELS OF OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: ION CHANNEL DYSFUNCTION AS A POSSIBLE PATHOGENETIC MECHANISM. 196
Totale 28.604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.021 0 0 0 0 0 0 470 505 305 265 172 304
2021/20222.010 147 252 179 179 171 165 79 91 112 130 174 331
2022/20233.550 434 806 333 313 272 575 78 193 251 69 121 105
2023/20243.401 112 168 174 158 389 706 623 161 240 94 95 481
2024/20259.336 449 1.032 827 426 789 378 681 327 944 1.207 848 1.428
2025/202617.745 5.256 3.124 3.576 2.170 2.273 1.281 65 0 0 0 0 0
Totale 48.024